These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37760632)

  • 1. Proximal Tibia Tumour Location and Curettage Are Major Risk Factors of Local Recurrence in Giant Cell Tumour of Bone.
    Mahdal M; Tomáš T; Apostolopoulos V; Adámková D; Múdry P; Staniczková Zambo I; Pazourek L
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for local recurrence in extremity-located giant cell tumours of bone with pathological fracture.
    Medellin MR; Fujiwara T; Tillman RM; Jeys LM; Gregory J; Stevenson JD; Parry M; Abudu A
    Bone Joint J; 2018 Dec; 100-B(12):1626-1632. PubMed ID: 30499317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative Denosumab With Curettage and Cryotherapy in Giant Cell Tumor of Bone: Is There an Increased Risk of Local Recurrence?
    Scoccianti G; Totti F; Scorianz M; Baldi G; Roselli G; Beltrami G; Franchi A; Capanna R; Campanacci DA
    Clin Orthop Relat Res; 2018 Sep; 476(9):1783-1790. PubMed ID: 30778015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of re-operation for local recurrence following pre-operative denosumab administration and curettage for giant cell tumour of bone with difficult joint preservation.
    Tsukamoto S; Hindiskere S; Honoki K; Mavrogenis AF; Tanaka Y; Chinder PS; Donati DM; Errani C
    Int Orthop; 2023 Jan; 47(1):265-273. PubMed ID: 36282294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical challenges, novel techniques, and systemic treatment of giant cell tumour of bone of the distal radius : clinical outcomes and systematic review of the literature.
    van der Heijden L; Bindt S; Scorianz M; Ng C; Gibbons MCLH; van de Sande MAJ; Campanacci DA
    Bone Jt Open; 2022 Jul; 3(7):515-528. PubMed ID: 35775196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended curettage versus en bloc resection for the treatment of grade 3 giant cell tumour of the knee with pathologic fracture: a retrospective study.
    Jamshidi K; Zandrahimi F; Haji Agha Bozorgi M; Arefpour AM; Bagherifard A; Al-Baseesee HH; Mirzaei A
    Int Orthop; 2021 Jan; 45(1):289-297. PubMed ID: 33001283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative denosumab treatment with curettage may be a risk factor for recurrence of giant cell tumor of bone.
    Sano K; Suehara Y; Okubo T; Sasa K; Kurihara T; Akaike K; Kubota D; Torigoe T; Hasegawa N; Ishii M; Nakamura Y; Kim Y; Takagi T; Kaneko K; Hayashi T; Saito T
    J Orthop Surg (Hong Kong); 2020; 28(2):2309499020929786. PubMed ID: 32539628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of Giant Cell Tumor of Bone in the Distal Radius and Ulna].
    Mahdal M; Jindra J; Staniczková Zambo I; Pazourek L; Nachtnebl L; Tomáš T
    Acta Chir Orthop Traumatol Cech; 2022; 89(3):188-192. PubMed ID: 35815484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of Reoperation for Local Recurrence Following En Bloc Resection for Bone Giant Cell Tumor of the Extremity.
    Tsukamoto S; Mavrogenis AF; Hindiskere S; Honoki K; Kido A; Fujii H; Masunaga T; Tanaka Y; Chinder PS; Donati DM; Errani C
    Curr Oncol; 2022 Sep; 29(9):6383-6399. PubMed ID: 36135072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Giant cell tumour of bone.
    Aoude A; Nikomarov D; Perera JR; Ibe IK; Griffin AM; Tsoi KM; Ferguson PC; Wunder JS
    Bone Joint J; 2023 May; 105-B(5):559-567. PubMed ID: 37121582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new computerized tomography classification to evaluate response to Denosumab in giant cell tumors in the extremities.
    Campanacci L; Sambri A; Medellin MR; Cimatti P; Errani C; Donati DM
    Acta Orthop Traumatol Turc; 2019 Sep; 53(5):376-380. PubMed ID: 31253385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is a Short-course of Preoperative Denosumab as Effective as Prolonged Therapy for Giant Cell Tumor of Bone?
    Hindiskere S; Errani C; Doddarangappa S; Ramaswamy V; Rai M; Chinder PS
    Clin Orthop Relat Res; 2020 Nov; 478(11):2522-2533. PubMed ID: 32401001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Navigation-guided En Bloc Resection Advantageous Compared With Intralesional Curettage for Locally Aggressive Bone Tumors?
    Farfalli GL; Albergo JI; Piuzzi NS; Ayerza MA; Muscolo DL; Ritacco LE; Aponte-Tinao LA
    Clin Orthop Relat Res; 2018 Mar; 476(3):511-517. PubMed ID: 29529633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes in Bone Giant Cell Tumors Treated With Surgical Resection With and Without Denosumab Injection: A Single-Institution Retrospective Study.
    AlYami AH; Nazer A; Bashawieh HH; Dabroom AA; Saem Aldahar M; AlYami AA; AlMaeen BN
    Cureus; 2022 Jul; 14(7):e26869. PubMed ID: 35978757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Denosumab in joint preservation for patients with giant cell tumour of bone.
    Perrin DL; Visgauss JD; Wilson DA; Griffin AM; Abdul Razak AR; Ferguson PC; Wunder JS
    Bone Joint J; 2021 Jan; 103-B(1):184-191. PubMed ID: 33380180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial.
    Rutkowski P; Gaston L; Borkowska A; Stacchiotti S; Gelderblom H; Baldi GG; Palmerini E; Casali P; Gronchi A; Parry M; Campanacci DA; Scoccianti G; Wagrodzki M; Ferrari S; Dijkstra S; Pieńkowski A; Grimer R
    Eur J Surg Oncol; 2018 Sep; 44(9):1384-1390. PubMed ID: 29650420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study.
    Urakawa H; Yonemoto T; Matsumoto S; Takagi T; Asanuma K; Watanuki M; Takemoto A; Naka N; Matsumoto Y; Kawai A; Kunisada T; Kubo T; Emori M; Hiraga H; Hatano H; Tsukushi S; Nishida Y; Akisue T; Morii T; Takahashi M; Nagano A; Yoshikawa H; Sato K; Kawano M; Hiraoka K; Tanaka K; Iwamoto Y; Ozaki T
    World J Surg Oncol; 2018 Aug; 16(1):160. PubMed ID: 30089488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Giant cell tumor of bone: A single center study of 115 cases.
    Deventer N; Budny T; Gosheger G; Rachbauer A; Puetzler J; Theil JC; Kovtun D; de Vaal M; Deventer N
    J Bone Oncol; 2022 Apr; 33():100417. PubMed ID: 35242511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Giant cell tumors of the distal ulna: long-term recurrence rate and functional outcomes of en bloc resection versus curettage in a multicenter study.
    Zhou L; Tang J; Shen L; Zhang Z; Yuan T
    J Orthop Surg Res; 2023 Sep; 18(1):743. PubMed ID: 37777754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant denosumab: its role and results in operable cases of giant cell tumour of bone.
    Puri A; Gulia A; Hegde P; Verma V; Rekhi B
    Bone Joint J; 2019 Feb; 101-B(2):170-177. PubMed ID: 30700112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.